BioSpace News Archive

Browse BioSpace’s published news and press releases by year, month, and day.
275 Results
Year
Month
Day
  • X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and development of novel therapies targeting diseases resulting from dysfunction of the CXCR4 pathway, today announced that its management team will participate in the following September virtual investor conferences: Citi 15 th Annual BioPharma Conference, Cantor Fitzgerald Virtual Global Healthcare Conference and Oppenheimer & Co. Fall Healthcare Life Sciences &
  • Atreca, Inc. (Atreca) (NASDAQ: BCEL), a biotechnology company focused on developing novel therapeutics generated through a unique discovery platform based on interrogation of the active human immune response, today announced that it will participate in the following upcoming virtual investor conferences: H.C. Wainwright & Co. 22 nd Annual Global Investment Conference 2020 Wednesday, September 16, 2020 Presentation time:
  • Todos Medical Ltd. (OTCQB: TOMDF) , an in vitro diagnostics company focused on distributing comprehensive solutions for COVID-19 screening and diagnosis, and developing blood tests for the early detection of cancer and Alzheimer’s disease, today announced sales for the month of August 2020 were $1,190,000. This compares with sales for the month of July 2020 of $550,000, with growth driven by week
  • PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that management will present a company overview at the Cantor Virtual Global Healthcare Conference on Thursday, September 17 th at 9:20 a.m. ET . The presentation will be webcast live on the Events and Presentations page under the investor relations section of P
  • CNS Pharmaceuticals, Inc., a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the central nervous system, provides an update on progress for the U.S. manufacturing of Berubicin, the Company’s lead drug candidate, in preparation for upcoming clinical trials.
  • IVERIC bio, Inc. (Nasdaq: ISEE) today announced that the Company will participate in the following upcoming virtual investor conferences in September: Citi 15 th Annual BioPharma Virtual Conference 2020 on Wednesday, September 9 and Thursday, September 10, 2020, IVERIC bio will host meetings with investors. Cantor Virtual Global Healthcare Conference 2020 on Wednesday, September 16, 2020 at 8:00 a.m. E
  • POXEL SA (Euronext – POXEL - FR0012432516), a biopharmaceutical company focused on the development of innovative treatments for metabolic disorders, including type 2 diabetes and non-alcoholic steatohepatitis (NASH), today announced that it will report and present its financial results for the first half 2020 on Tuesday, September 15, 2020. The management team will host a conference call on September 15, 2020 in Engl
  • - In lieu of an in-person update to the media, Dr. Theresa Tam , Canada’s Chief Public Health Officer, issued the following statement today: “There have been 129,923 cases of COVID-19 in Canada , including 9,135 deaths. 88.5% of people have now recovered. Labs across Canada tested an average of 46,000 people daily over the past
  • Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, today announced that Dirk Allison, President and Chief Executive Officer, and Brian Poff , Executive Vice President and Chief Financial Officer, will participate in the Baird 2020 Global Healthcare Conference, which is being held as a virtual event on
  • A collaboration between Cummins Inc. and the Carbon Fiber Technology Facility at the Department of Energy’s Oak Ridge National Laboratory has resulted in the ability to produce enough filter media to supply more than a million face masks and respirators per day to U.S. healthcare facilities.